Biotech · Private company
Cook MyoSite
Track this companyFree. Adds Cook MyoSite to your Dealase workspace and tells you when its record changes.
Clinical trials106 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AMDC-USR (iltamiocel)Phase 3 · Stress Urinary IncontinenceClinicalTrials.gov · fetched Nov 12, 2026
- IltamiocelPhase 3 · Fecal IncontinenceClinicalTrials.gov · fetched Nov 12, 2026
- IltamiocelPhase 3 · Stress Urinary IncontinenceClinicalTrials.gov · fetched Nov 12, 2026
- autologous muscle cell injectionPhase 2 · Stress Urinary IncontinenceClinicalTrials.gov · fetched Nov 12, 2026
- autologous muscle-derived cells (AMDC)Phase 2 · Urinary IncontinenceClinicalTrials.gov · fetched Nov 12, 2026
- Autologous Muscle Derived Cells (AMDCs)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- REVIVE Prospective Registry Cohort StudyNOT_YET_RECRUITING · started Aug 30, 2026ClinicalTrials.gov NCT07429890 · fetched Nov 12, 2026
- Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinenceENROLLING_BY_INVITATION · started Apr 11, 2025ClinicalTrials.gov NCT06743620 · fetched Nov 12, 2026
- Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric InjuryPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 21, 2024ClinicalTrials.gov NCT05776277 · fetched Nov 12, 2026
- Autologous Muscle Derived Cells for Treatment of Tongue DysphagiaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started May 26, 2022ClinicalTrials.gov NCT05421689 · fetched Nov 12, 2026
- Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinencePHASE3 · ACTIVE_NOT_RECRUITING · started Apr 23, 2019ClinicalTrials.gov NCT03104517 · fetched Nov 12, 2026
- Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue DysphagiaPHASE1 · ACTIVE_NOT_RECRUITING · started May 24, 2017ClinicalTrials.gov NCT02838316 · fetched Nov 12, 2026
- Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate SurgeryPHASE1_PHASE2 · COMPLETED · started Feb 19, 2015ClinicalTrials.gov NCT02291432 · fetched Nov 12, 2026
- Autologous Muscle Derived Cells for Female Urinary Sphincter RepairPHASE3 · COMPLETED · started Nov 21, 2013ClinicalTrials.gov NCT01893138 · fetched Nov 12, 2026
- An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary IncontinencePHASE2 · COMPLETED · started Oct 9, 2008ClinicalTrials.gov NCT00847535 · fetched Nov 12, 2026
- Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)TEMPORARILY_NOT_AVAILABLEClinicalTrials.gov NCT04661293 · fetched Nov 12, 2026